RxDoctor Payments Data

Kedar Kakodkar, MD

Otolaryngology · Munster, INNPI 1073724076

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Optinose US, Inc. at 46.6% of the total. Reporting peaked in 2019 at $2,837 and has fallen 69.9% since, to $854 in 2025.

$7,107in general payments, 2019–2025

Across 122 payments — averaging $58.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$3K
  • Aerin Medical Inc.$1K
  • Integra Lifesciences Corporation$776
  • Intersect ENT, Inc.$455
  • Inspire Medical Systems, Inc.$400
  • Stryker$258
  • plus $678 from 10 others

What the payments were for

  • Consulting fees$2,50035%
  • Travel & lodging$5418%
  • Food & beverage$4,06657%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,107 in reported general payments places this provider in the 80th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$68,751
Medicare patients
277
Services billed
767

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl139$2,612
Ofloxacin31$1,811
Fluticasone Propionate119$960
CefuroximeCefuroxime Axetil24$456
Ipratropium Bromide23$295
Ciprofloxacin Hcl12$93
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$84

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Munster

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →